| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $4,370,025 | 17 | 100 |
| Prange Karen | director | 0 | $0 | 2 | $224,233 | $-224,233 |
| Yuen Maggie | director | 0 | $0 | 2 | $241,630 | $-241,630 |
| GROVES REGINA E | director | 0 | $0 | 1 | $288,071 | $-288,071 |
| Noznesky Justin J | Chief Mktg & Strategy Officer | 0 | $0 | 2 | $432,502 | $-432,502 |
| Dahlquist Karl S. | Chief Legal Officer | 0 | $0 | 1 | $458,099 | $-458,099 |
| Doraiswamy Vinayak | Chief Scientific Officer | 0 | $0 | 3 | $523,080 | $-523,080 |
| Privitera Salvatore | Chief Technical Officer | 0 | $0 | 3 | $879,833 | $-879,833 |
| WEHRWEIN SVEN | director | 0 | $0 | 3 | $1.32M | $-1.32M |
AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform …
Over the last 12 months, insiders at AtriCure, Inc. have bought $0 and sold $4.37M worth of AtriCure, Inc. stock.
On average, over the past 5 years, insiders at AtriCure, Inc. have bought $111,250 and sold $1.67M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $111,250 was made by Privitera Salvatore (Chief Technical Officer) on 2024‑05‑30.
| 2026-09-23 | Sale | Privitera Salvatore | Chief Technical Officer | 4,519 0.0089% | $60.00 | $271,140 | -3.81% | |
| 2026-09-11 | Sale | GROVES REGINA E | director | 5,313 0.0109% | $54.22 | $288,071 | +5.94% | |
| 2026-09-08 | Sale | Privitera Salvatore | Chief Technical Officer | 3,657 0.0077% | $55.00 | $201,135 | +7.33% | |
| 2026-09-02 | Sale | Privitera Salvatore | Chief Technical Officer | 7,763 0.0152% | $52.50 | $407,558 | +8.96% | |
| 2026-08-24 | Sale | Dahlquist Karl S. | Chief Legal Officer | 9,370 0.0192% | $48.89 | $458,099 | +14.89% | |
| 2026-08-05 | Sale | Prange Karen | director | 3,564 0.0069% | $38.80 | $138,283 | +41.15% | |
| 2026-08-05 | Sale | Yuen Maggie | director | 3,500 0.0067% | $38.42 | $134,470 | +41.15% | |
| 2026-07-29 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 6,182 0.0115% | $38.80 | $239,862 | +32.39% | |
| 2026-07-28 | Sale | Doraiswamy Vinayak | Chief Scientific Officer | 6,000 0.0116% | $38.88 | $233,280 | +35.17% | |
| 2026-07-28 | Sale | WEHRWEIN SVEN | director | 25,000 0.047% | $37.84 | $946,000 | +35.17% | |
| 2026-05-20 | Sale | Prange Karen | director | 3,000 0.0059% | $28.65 | $85,950 | +50.21% | |
| 2026-05-15 | Sale | Doraiswamy Vinayak | Chief Scientific Officer | 5,000 0.0099% | $28.13 | $140,650 | +53.70% | |
| 2026-03-12 | Sale | Doraiswamy Vinayak | Chief Scientific Officer | 5,000 0.0101% | $29.83 | $149,150 | +13.95% | |
| 2025-11-26 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 5,166 0.0108% | $37.29 | $192,640 | +0.62% | |
| 2025-11-25 | Sale | WEHRWEIN SVEN | director | 4,967 0.0105% | $38.00 | $188,746 | -5.93% | |
| 2025-11-24 | Sale | WEHRWEIN SVEN | director | 5,033 0.0104% | $37.32 | $187,832 | -3.93% | |
| 2025-11-21 | Sale | Yuen Maggie | director | 3,000 0.006% | $35.72 | $107,160 | +0.39% | |
| 2025-09-12 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 3,000 0.0062% | $36.30 | $108,900 | -1.50% | |
| 2025-08-22 | Sale | WEHRWEIN SVEN | director | 5,000 0.0099% | $37.00 | $185,000 | -8.27% | |
| 2025-08-19 | Sale | WEHRWEIN SVEN | director | 5,000 0.0101% | $36.00 | $180,000 | -3.60% |
| Privitera Salvatore | Chief Technical Officer | 142745 0.2806% | $8.62M | 1 | 14 | +40.88% |
| GROVES REGINA E | director | 34546 0.0679% | $2.09M | 3 | 5 | +38.8% |
| Discovery Group I, LLC | 10 percent owner | 1621334 3.1874% | $97.94M | 47 | 25 | +15.37% |
| ROBARDS KAREN P | director | 288328 0.5668% | $17.42M | 23 | 3 | +76.77% |
| Drachman David J | President and CEO | 146000 0.287% | $8.82M | 4 | 15 | <0.0001% |
| Piton Julie A | VP Fin & Admin & CFO | 85922 0.1689% | $5.19M | 1 | 2 | <0.0001% |
| Collar Mark A | director | 77307 0.152% | $4.67M | 2 | 10 | <0.0001% |
| LUX ANDREW L | SVP, Ops & Quality | 65589 0.1289% | $3.96M | 1 | 2 | +17.91% |
| Seith Douglas J | Chief Operating Officer | 64711 0.1272% | $3.91M | 2 | 15 | +43.56% |
| Hooven Michael D | director | 57049 0.1122% | $3.45M | 7 | 8 | <0.0001% |
| Drake Scott William | director | 41036 0.0807% | $2.48M | 2 | 2 | +73.02% |
| JOHNSTON RICHARD M | director | 34727 0.0683% | $2.1M | 1 | 21 | +13.46% |
| Lanning Mark R | director | 25000 0.0491% | $1.51M | 3 | 0 | +43.44% |
| Krell Elizabeth D | director | 19967 0.0393% | $1.21M | 1 | 12 | <0.0001% |
| JOHNSON B KRISTINE | director | 10969 0.0216% | $662,637.29 | 1 | 0 | +27.76% |
| Walsh Richard S | Vice President; Sales | 1750 0.0034% | $105,717.50 | 2 | 0 | <0.0001% |
| Increased Positions | 134 | +60.09% | 7M | +13.95% |
| Decreased Positions | 95 | -42.6% | 5M | -11.43% |
| New Positions | 40 | New | 4M | New |
| Sold Out Positions | 24 | Sold Out | 3M | Sold Out |
| Total Postitions | 262 | +17.49% | 49M | +2.52% |
| Vanguard Group Inc | $190,102.00 | 9.68% | 4.84M | -65,324 | -1.33% | 2025-09-30 |
| Wellington Management Group Llp | $168,550.00 | 8.58% | 4.29M | +322,818 | +8.13% | 2025-09-30 |
| Blackrock, Inc. | $156,966.00 | 7.99% | 4M | -25,359 | -0.63% | 2025-09-30 |
| Alliancebernstein L.P. | $139,746.00 | 7.12% | 3.56M | -15,057 | -0.42% | 2025-09-30 |
| Hood River Capital Management Llc | $119,600.00 | 6.09% | 3.05M | -15,472 | -0.51% | 2025-09-30 |
| Macquarie Group Ltd | $89,904.00 | 4.58% | 2.29M | -213,836 | -8.54% | 2025-09-30 |
| Champlain Investment Partners, Llc | $77,684.00 | 3.96% | 1.98M | -38,541 | -1.91% | 2025-09-30 |
| State Street Corp | $49,649.00 | 2.53% | 1.26M | -9,443 | -0.74% | 2025-09-30 |
| Neuberger Berman Group Llc | $46,775.00 | 2.38% | 1.19M | +1,372 | +0.12% | 2025-09-30 |
| Geode Capital Management, Llc | $46,773.00 | 2.38% | 1.19M | +9,318 | +0.79% | 2025-09-30 |